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Abstract The prevalence of chronic diseases has risen
along with increased longevity. Co-occurrence of two or
more chronic diseases in an individual (multimorbidity)
is prevalent and poses a huge burden to individuals and
the society. However, determinants of multimorbidity are
largely unknown. Handgrip strength is a general indica-
tor of muscle strength and linked with premature mor-
tality. However, its role in multimorbidity has never
been evaluated. To investigate the relationships between
handgrip strength and multiple chronic diseases and
multimorbidity, and to assess the usefulness of age and
handgrip as a marker of chronic diseases and multi-
morbidity in a community dwelling sample of men
and women, we analyzed a cross-sectional cohort with
1,145 subjects (748 men and 397 women) aged 50 years
and older living in Hong Kong. Low handgrip strength
was significantly associated with increased odds of hav-
ing five and three chronic diseases in men and women,
respectively, after controlling for age, body mass index,
history of smoking, educational level, marital level and
comorbidity. Multivariable-adjusted handgrip strength
was significantly decreased with the number of chronic
diseases in men (trend, P00.001), but the trend in
women was marginal (trend, P00.06). Conversely,
multivariable-adjusted age was significantly increased
with the number of chronic diseases in women (trend,
P00.033), but not in men (trend, P00.118). In conclu-
sion, handgrip strength is associated with multiple
chronic diseases and multimorbidity in men and women
after adjustment of confounding factors. It shows a
linear trend of association with the number of chronic
diseases in men, but not in women. Since handgrip
strength is a biomarker of multiple physiological sys-
tems, its augmentation may be a feasible strategy to
improve general health and decrease likelihood of hav-
ing multiple chronic diseases and hence, premature
mortality.
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Introduction
The prevalence of chronic diseases has risen along with
longevity (Knottnerus et al. 1992), and the prevalence is
expected to rise further owing to an aging population. In
addition, people usually suffer from more than one
chronic disease. There are two terms describing the
disease co-occurrence: comorbidity and multimorbidity.
Comorbidity refers to having a number of other diseases
beyond the index disease under study. In contrast, multi-
morbidity is defined as any co-occurrence of two or
more chronic diseases within the same person (van den
Akker et al. 1996).
Multimorbidity is highly prevalent and poses a
huge burden on individuals and society. In a general
population of 13,584 Dutch subjects, the prevalence of
multimorbidity in subjects aged 65–74 years was 30%
and in those aged 75 years or above was 55% (Schram
et al. 2008). Previous studies have shown that multi-
morbidity increases the mortality risk (Marengoni et
al. 2011; Newman et al. 2008), causes a decline of
physical and mental functioning (Marengoni et al.
2009, 2011), and adversely influences quality of life
(Fortin et al. 2006; Marengoni et al. 2011; Tooth et al.
2008). Additionally, it is also associated with needing
help with activities of daily living, longer hospitaliza-
tion, and higher overall health service utilization
(Marengoni et al. 2011; Tooth et al. 2008).
Although multimorbidity poses a major problem to
individuals, health care providers and society, research
of multimorbidity is still in its infancy (Fortin et al.
2005, 2007). A few factors have been shown to be
associated with multimorbidity. For example, age is a
well-known determinant of multimorbidity, as the
number of co-existing diseases in a person rises with
age (Marengoni et al. 2008; Schellevis et al. 1993; van
den Akker et al. 1998). Female gender, lower socio-
economic status, lower education, smoking, high waist
circumference, and separated or divorced or widowed
in marital status were also associated with increased risk
of multimorbidity (Marengoni et al. 2008; Taylor et al.
2010). However, biomechanical determinants of multi-
morbidity are still poorly understood. Despite recent
research interests in handgrip strength, the association
between handgrip strength and multimorbidity has, to
our knowledge, never been evaluated.
Handgrip strength is a general indicator of muscle
strength, and low handgrip strength has been linked
with premature mortality in middle-aged and elderly
subjects (Metter et al. 2002; Takata et al. 2007). In
addition, handgrip strength may serve as a biomarker
of other systems, such as the endocrine system. A
randomized controlled trial reported that sex steroid
plus growth hormone intervention significantly in-
creased muscle strength in men, but not in women
(Blackman et al. 2002), and this observation was fur-
ther supported by a meta-analysis (Ottenbacher et al.
2006). These observations suggested that handgrip
strength may be controlled by multiple physiological
systems. Earlier studies suggested that handgrip
strength is associated with a number of chronic dis-
eases (Fried et al. 2001; Karkkainen et al. 2008; Oken
et al. 2008; Sayer et al. 2007; Syddall et al. 2003).
However, many of these studies were based on a
single disease paradigm and did not account for
comorbidity or multimorbidity. Therefore, the first
aim of the current study was to evaluate the relation-
ship between handgrip strength and each individual
chronic disease with adjustment for comorbidity. The
second aim was to investigate whether handgrip
strength was associated with multimorbidity, and if it
was better than age as a marker of multimorbidity.
Material and methods
This handgrip strength study formed part of the Hong
Kong Osteoporosis Study which was initiated in 1995.
The population cohort participants were community-
dwelling Southern Chinese men and women recruited
from public road shows and health fairs held in vari-
ous districts of Hong Kong. From 1998 to 2009, a total
of 9,353 southern Chinese men and women were
recruited. Handgrip strength data were first collected
at the end of 2002. A total of 4,861 subjects had
handgrip strength data. Subjects under the age of 50
(n02,025) were excluded, as were subjects who re-
fused to answer the section on the questionnaire re-
garding medical history (missing total sections of the
medical history) (n01,574). In the remaining 1,262
subjects, 58 men and 59 women with at least one
missing data (on any chronic disease) were also ex-
cluded. Missing data were due in large part to subjects
being uncertain whether they suffered from particular
chronic diseases. Data from 748 men and 397 women
were analyzed in the present study. Study recruitment
and eligibility flow chart is provided in Fig. S1. All
participants gave informed consent and the study was
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conducted according to the Declaration of Helsinki.
The study protocol was approved by the Institutional
Review Board of the University of Hong Kong and the
Hospital Authority Hong Kong West Cluster Hospitals.
Collection of clinical data and selection of chronic
diseases
In brief, baseline demographic data on anthropometric
measurements, socioeconomic status, education level,
and medical and reproductive history were obtained
using a structured questionnaire administered by a re-
search nurse or assistant. The medical record was con-
firmed by using the computerized patient record system
of the Hong Kong Hospital Authority, which manages
outpatient clinics and hospitals attended by the majority
(94%) of Hong Kong population. Lifestyle and dietary
habits, including smoking, alcohol consumption, and
physical activity, were also recorded. Details of this
have been described previously (Cheung et al. 2006;
Tang et al. 2009; Tsang et al. 2009).
In the current study, we selected 18 chronic diseases
that were present in our database and also prevalent
(defined by ≥1%) in our study population. Five chronic
diseases (parkinsonism, malabsorption, hyperparathyroid-
ism, dementia, and rheumatoid arthritis) were excluded
due to the prevalence of <1%. Stages of chronic kidney
disease (CKD) were determined using the estimated glo-
merular filtration rate (eGFR) and the following equation
(Ma et al. 2006):
eGFR ml=min per 1:73 m2
 
¼ 186 plasma creatinine mg=dlð Þ1:154  age0:203
 0:742 if femaleð Þ  1:233 if Chineseð Þ
Subjects with eGFR <60 were classified as having
CKD stage 3 or above. All other conditions were self-
reported by answering survey questions such as “Do
you have or have you had…?”
The 18 chronic diseases included: (1) anaemia, 2)
anxiety, (3) cataract, (4) cerebral vascular accident
(stroke), (5) CKD stage 3 or above, (6) chronic obstruc-
tive airways disease, (7) depression, (8) diabetes, (9)
history of fall in the past 12 months, (10) hepatitis B,
(11) hyperlipidaemia, (12) hypertension, (13) hyperthy-
roidism, (14) ischemic heart diseases, (15) kyphosis,
(16) malignancy within 5 years, (17) osteoarthritis knee,
and (18) peptic ulcer. These 18 chronic diseases were
based on the 12 categories of the World Health
Organization’s International Classification of Diseases
(10th Revision, version for 2007, http://apps.who.int/
classifications/apps/icd/icd10online/) (Table S1).
Handgrip strength and covariate assessment
Baseline handgrip strength (in kg) wasmeasured using a
dynamometer (Smedley Hand Dynamometer, Stoelting
Co, Wood Dale, IL). The test was administered by a
trained nurse, and the mean score of three measures in
the dominant hand was used in the analysis (Cheung et
al. 2011).
Since the aim of our study was to investigate the
relationship of handgrip strength and chronic diseases
and multimorbidity in an aged population, transforma-
tion of the handgrip strength measurements to T-scores
enabled us to assess handgrip strength with increasing
age. We computed a score for standardized handgrip
strength for each individual using the formula:
Standardized handgrip strength T score
¼ handgrip strength value reference meanð Þ
=reference standard deviation SDð Þ:
The age group (30–39 years) with highest mean
handgrip strength served as the reference group for
the other age groups (Cheung et al. 2011).
Age was obtained in the questionnaire. Height was
measured without shoes to the nearest 0.1 cm using a
wall-mounted stadiometer. Weight was measured to
the nearest 0.1 kg using an electrical scale, with the
subject wearing light indoor clothing.
Statistical analysis
We calculated odds ratios (OR) and 95% confidence
interval (CI) for each dichotomized chronic disease
using logistic regression. Univariable and multivari-
able models were performed. In the simple multivari-
able model (model 2), age, body mass index (BMI),
history of smoking, educational level and marital sta-
tus were adjusted. To eliminate the potential con-
founding effects of comorbidity, we adjusted for all
other chronic diseases in the full model (model 3). We
also used analysis of covariance (ANCOVA) to com-
pare least-squares adjusted handgrip strength and
chronological age among subjects with increasing
number of co-existing chronic diseases and to test for
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a linear trend. The ANCOVA model included age,
handgrip strength, BMI, history of smoking, educational
level and marital status. A value of p≤0.05 was consid-
ered statistically significant. All statistical analyses were
performed using SPSS V16.0.2 software.
Results
On average, men were significantly younger and had
higher BMI than women in the study. The mean (SD)
handgrip strength and its T score were 30.7 (7.9) and
−1.22 (0.93) in men, respectively. The corresponding
mean (SD) handgrip strength and its T-score in women
were 16.8 (6.4) and −1.45 (1.25), respectively. Among
the 18 chronic diseases, ischemic heart disease was
significantly more prevalent in men, while anaemia,
cataract, history of fall in the past 12 months and
hyperthyroidism were significantly more prevalent in
women (Table 1). The prevalence of each chronic
disease in studied men and women is shown in
Table 1.
The associations between each chronic disease per
each SD decrease in handgrip strength in men and
women are shown in Tables 2 and 3, respectively. In
men, decreased handgrip strength was associated with
increased odds of 12 chronic diseases. After adjusting
for age, BMI, history of smoking, educational level
and marital status, the associations between handgrip
strength and stroke, CKD stage 3 or above, diabetes,
history of fall in the past 12 months, and hyperthy-
roidism remained significant. After further adjusting
for co-existing diseases, the associations with stroke
(OR01.68, 95% CI01.10–2.58, P00.017), CKD
stage 3 or above (OR02.76, 95% CI01.59–4.78,
P<0.001), and hyperthyroidism (OR01.92, 95% CI0
1.11–3.30, P00.019) remained significant, whereas the
associations with anxiety (OR03.57, 95% CI01.46–
8.77, P00.005) and chronic obstructive airways dis-
eases (OR02.19, 95% CI01.05–4.55, P00.036) be-
came significant.
In women, decreased handgrip strength was asso-
ciated with increased odds of eight chronic diseases.
After adjustment of age, BMI, history of smoking,
educational level and marital status, the associations
between handgrip strength and anaemia, stroke, history
of fall in the past 12 months, and kyphosis remained
significant. After further adjusted for co-existing diseases,
low handgrip strength remained robustly associated with
increased odds of anaemia (OR01.83, 95% CI01.14–
2.92, P00.012), history of fall in the past 12 months
(OR01.44, 95%CI01.15–1.81, P00.002), and kyphosis
(OR01.80, 95% CI01.32–2.46, P<0.001).
The results of multivariable analyses of chronolog-
ical age and handgrip strength as markers of multi-
morbidity in men and women are shown in Table 4. In
men, chronological age was associated with four
chronic diseases, whereas handgrip strength was asso-
ciated with five chronic diseases. In women, chrono-
logical age was associated with five chronic diseases,
whereas handgrip strength was associated with three
chronic diseases. Interestingly, in both men and women,
the diseases associated with chronological age and
handgrip strength were mutually exclusive.
The results of multivariable ANCOVA analysis of
age and handgrip strength as a marker of multimor-
bidity are shown in Figs. 1 and 2. For the analysis of
age (Fig. 1), there was a significant positive linear
trend between age and number of chronic diseases in
women (trend, P00.033), but not in men (trend,
P00.118; Fig. 1). In men, subjects without chronic
disease were significantly younger than subjects hav-
ing one to six chronic diseases. In women, subjects
without chronic disease were significantly younger
than subjects having two and four to seven chronic
diseases. For the analysis of handgrip strength (Fig. 2),
there was a significant negative linear trend between
handgrip strength and number of chronic diseases in
men (trend, P00.001), but not in women (trend,
P00.06; Fig. 2). In men, subjects without chronic
disease had significantly higher handgrip strength
T-score than subjects having two to eight chronic dis-
eases. In women, subjects without chronic disease had
significantly higher handgrip strength than subjects
having four, and seven chronic diseases.
Discussion
To our best knowledge, this study is the first study
demonstrating that handgrip strength is associated
with multimorbidity, and that handgrip strength may
be a more useful marker of multimorbidity than chro-
nological age in men. Moreover, we also demonstrated
that handgrip strength was associated with different
chronic diseases, even when comorbidity and other
confounding factors were taken into account. In pre-
vious studies, low handgrip strength has been linked
932 AGE (2013) 35:929–941
with premature mortality in middle-aged and elderly
subjects. Our current findings provide a possible ex-
planation: premature mortality could be due to the
presence of multiple chronic diseases.
It is a common perception that handgrip strength is
related mainly to the muscular system (Filho et al.
2010). In this study, we showed that handgrip strength
was associated with multiple chronic diseases after
controlling for comorbidity. These diseases may be
related but not necessarily restricted to muscular sys-
tem, including anaemia, anxiety, CKD stage 3 or
above, chronic obstructive airways disease, diabetes,
hyperthyroidism, stroke, and kyphosis. It is not sur-
prising that handgrip strength is significantly associat-
ed with a history of fall, as handgrip strength is an
indicator of general muscle strength and associated
Table 1 Demographic characteristics and prevalence of each disease in all subjects
Male Female P valuea
Mean SD Mean SD
n 748 397
Age (years) 70.7 7.6 72 10.7 0.036
BMI 23.2 3.3 22.1 4.2 <0.001
Handgrip strength (kg) 30.7 7.9 16.8 6.4 <0.001
Handgrip strength T score −1.2 0.9 −1.5 1.3 <0.001
n % n % P valueb
Educational level <0.001
No 60 8 187 47.1
Primary 174 23.3 112 28.2
Secondary 324 43.3 77 19.4
College or university 190 25.4 21 5.3
Single 36 4.8 57 14.4 <0.001
Divorced 58 7.8 143 36 <0.001
History of smoker 288 38.5 28 7.1 <0.001
Anaemia 16 2.1 22 5.5 0.003
Anxiety 12 1.6 5 1.3 0.800
Cataract 61 8.2 123 31.0 <0.001
Cerebral vascular accident (stroke) 44 5.9 26 6.5 0.698
Chronic kidney disease stage 3 or above 34 4.5 29 7.3 0.057
Chronic obstructive airways disease 21 2.8 4 1.0 0.055
Depression 10 1.3 12 3.0 0.068
Diabetes 141 18.9 83 20.9 0.434
History of fall in the past 12 months 110 14.7 199 50.1 <0.001
Hepatitis B 15 2.0 7 1.8 1
Hyperlipidaemia 153 20.5 86 21.7 0.647
Hypertension 361 48.3 200 50.4 0.535
Hyperthyroidism 26 3.5 24 6.0 0.049
Ischemic heart diseases 61 8.2 17 4.3 0.013
Kyphosis 77 10.3 55 13.9 0.080
Malignancy within 5 years 40 5.3 24 6.0 0.685
Osteoarthritis knee 130 17.4 66 16.6 0.805
Peptic ulcer 56 7.5 19 4.8 0.080
aP value was calculated by independent t-test
bP value was calculated by chi-square test
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with lower extremity strength (Norman et al. 2010;
Samson et al. 2000; Xue et al. 2010). For other non-
musculoskeletal diseases, it could be that handgrip
strength may be associated with endocrine or other
physiologic systems.
It has been reported that both subclinical inflamma-
tion and insulin resistance are risk factors for low
muscle strength (Abbatecola et al. 2005; Barzilay et
al. 2009; Schaap et al. 2009). In addition, a recent
study suggested that long-term exposure to obesity is
associated with poor handgrip strength later in life
(Stenholm et al. 2011), further suggesting that low
handgrip strength could be a marker reflecting the
presence of subclinical inflammation and defects in
glucose metabolism. It is well acknowledged that re-
duced muscle strength is a consequence of stroke.
However, in a recent population-based cohort study
of 1 million Swedish men, reduced handgrip strength
was associated with increased risk of incident coro-
nary heart disease and all strokes (Silventoinen et al.
2009), after adjustment of various confounding fac-
tors, such as birth cohort, age, BMI, height, blood
pressure, and occupational socioeconomic position,
suggesting that low handgrip strength is not only a
marker, but also a predictor of coronary heart disease
and stroke. Nevertheless, these observations suggested
that handgrip strength is associated with multiple
physiological systems and the mechanisms underlying
handgrip strength deterioration, such as insulin resis-
tance, hyperthyroidism (Harrison and Clausen 1998;
Wang et al. 2006), increased interleukin-6 or reduced
insulin-like growth factor I (IGF-I) (Barbieri et al.
2003), are common to other diseases.
In this study, the association patterns of handgrip
strength with chronic diseases in men and women
were very different. This could be due to the intrinsic
differences between both genders, such as sex hor-
mones. Earlier study suggested that sex hormone status
is an important factor of handgrip strength in men but
not in women (Baumgartner et al. 1999). Subsequently a
Table 2 Binary logistic regression analysis of each SD reduction in handgrip strength with chronic diseases in men
Chronic diseases Model 1 Model 2 Model 3
OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value
Anaemia 1.82 (1.09–3.05) 0.022 1.37 (0.74–2.55) 0.320 0.68 (0.28–1.63) 0.384
Anxiety 1.52 (0.84–2.75) 0.169 1.98 (0.98–4.00) 0.056 3.57 (1.46–8.77) 0.005
Cataract 1.51 (1.14–1.99) 0.004 1.30 (0.93–1.81) 0.127 1.21 (0.84–1.75) 0.312
Cerebral vascular accident (Stroke) 2.07 (1.49–2.87) <0.001 1.85 (1.25–2.72) 0.002 1.68 (1.10–2.58) 0.017
CKD stage 3 or above 2.89 (1.97–4.24) <0.001 2.71 (1.71–4.31) <0.001 2.76 (1.59–4.78) <0.001
COAD 2.48 (1.56–3.91) <0.001 1.74 (0.98–3.09) 0.059 2.19 (1.05–4.55) 0.036
Depression 0.74 (0.37–1.48) 0.398 0.56 (0.24–1.32) 0.186 0.35 (0.11–1.10) 0.072
Diabetes 1.42 (1.17–1.73) 0.001 1.39 (1.09–1.76) 0.007 1.28 (0.99–1.66) 0.063
Hepatitis B 1.49 (0.87–2.53) 0.146 1.55 (0.82–2.93) 0.182 1.56 (0.78–3.12) 0.209
History of fall in the past 12 months 1.53 (1.23–1.90) <0.001 1.44 (1.11–1.87) 0.006 1.31 (0.99–1.73) 0.059
Hyperlipidaemia 0.99 (0.81–1.19) 0.891 1.04 (0.83–1.31) 0.740 0.99 (0.76–1.28) 0.932
Hypertension 1.29 (1.10–1.51) 0.001 1.13 (0.93–1.37) 0.218 0.99 (0.80–1.22) 0.901
Hyperthyroidism 1.58 (1.05–2.38) 0.029 1.75 (1.08–2.82) 0.024 1.92 (1.11–3.30) 0.019
Ischemic heart diseases 1.49 (1.13–1.97) 0.005 1.30 (0.93–1.82) 0.120 1.32 (0.90–1.93) 0.157
Kyphosis 1.44 (1.12–1.85) 0.004 1.31 (0.97–1.76) 0.082 1.22 (0.88–1.67) 0.231
Malignancy within 5 years 1.47 (1.05–2.05) 0.025 1.17 (0.78–1.75) 0.460 1.16 (0.75–1.79) 0.499
Osteoarthritis knee 0.99 (0.81–1.21) 0.927 1.04 (0.82–1.32) 0.748 1.02 (0.78–1.32) 0.905
Peptic ulcer 1.08 (0.81–1.44) 0.608 1.06 (0.75–1.50) 0.743 0.90 (0.62–1.31) 0.570
P≤0.05 values are in bold
Model 1: unadjusted model; model 2: adjusted for age, BMI, educational level, history of smoking and marital status; model 3: adjusted
for age, BMI, history of smoking, educational level, marital status and other co-existing chronic diseases
CKD chronic kidney disease, COAD chronic obstructive airways disease
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number of studies have investigated the relationship
between sex hormone and muscle mass or strength.
Page et al. (2005) reported that exogenous testosterone
improved handgrip strength in older men (Page et al.
2005). Conversely, in a randomized control trial study of
Women’s Health Initiative, hormone therapy in post-
menopausal women did not improve the grip strength
(Michael et al. 2010). These observations are actually in
agreement with an earlier randomized controlled trial
which reported that sex steroid and growth hormone
intervention significantly increased muscle strength in
men, but not women (Blackman et al. 2002), suggesting
that sex hormones may exert the effect on handgrip
strength differently or through different mechanisms in
men and women.
Handgrip strength appeared to be more important in
determining multimorbidity than chronological age in
men. Syddall et al. (2003) reported that grip strength
was associated with more markers of frailty than chro-
nological age in 717 men and women within a narrow
age range (aged 64–74 years). Our study is in agree-
ment with this study, as this observation was also
observed in men and marginally in women. In men,
we observed that chronological age was significantly
associated with cataract, hypertension, ischemic heart
diseases and kyphosis, whereas handgrip strength was
significantly associated with anxiety, stroke, CKD
stage 3 or above, chronic obstructive airways disease
and hyperthyroidism. The importance of handgrip
strength was further strengthened by the ANCOVA
analysis, showing that there was a statistically signif-
icant inverse linear trend association between hand-
grip strength and number of co-existing chronic
diseases. However, the linear trend was not observed
between chronological age and number of co-existing
chronic diseases, suggesting handgrip strength could
be a marker of multimorbidity and independent of the
effect of age and other confounding factors.
Chronological age, however, appeared to be more
important in determining multimorbidity than handgrip
Table 3 Binary logistic regression analysis of each SD reduction in handgrip strength with chronic diseases in women
Chronic diseases Model 1 Model 2 Model 3
OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value
Anaemia 1.82 (1.28–2.58) 0.001 1.65 (1.09–2.52) 0.019 1.83 (1.14–2.92) 0.012
Anxiety 1.09 (0.54–2.20) 0.802 1.16 (0.48–2.79) 0.742 1.46 (0.36–6.02) 0.597
Cataract 1.34 (1.12–1.60) 0.001 0.97 (0.78–1.22) 0.810 0.91 (0.71–1.17) 0.457
Cerebral vascular accident (stroke) 1.78 (1.29–2.46) 0.001 1.57 (1.06–2.32) 0.023 1.29 (0.78–2.11) 0.320
CKD stage 3 or above 1.68 (1.23–2.28) 0.001 1.03 (0.68–1.56) 0.899 1.04 (0.64–1.68) 0.868
COAD 2.09 (0.96–4.57) 0.063 1.99 (0.73–5.38) 0.176 4.93 (0.50–48.85) 0.172
Depression 1.00 (0.63–1.58) 0.992 0.82 (0.44–1.51) 0.525 0.74 (0.35–1.54) 0.420
Diabetes 1.46 (1.19–1.79) <0.001 1.24 (0.97–1.58) 0.088 1.21 (0.90–1.63) 0.208
Hepatitis B 0.62 (0.34–1.14) 0.125 0.51 (0.22–1.14) 0.099 0.65 (0.26–1.64) 0.363
History of fall in the past 12 months 1.39 (1.17–1.64) <0.001 1.43 (1.16–1.76) 0.001 1.44 (1.15–1.81) 0.002
Hyperlipidaemia 0.95 (0.79–1.15) 0.624 0.99 (0.78–1.25) 0.926 0.89 (0.68–1.17) 0.390
Hypertension 1.40 (1.19–1.66) <0.001 1.07 (0.86–1.32) 0.543 1.02 (0.79–1.30) 0.906
Hyperthyroidism 0.95 (0.68–1.32) 0.762 1.06 (0.70–1.62) 0.771 1.11 (0.68–1.81) 0.689
Ischemic heart diseases 1.32 (0.90–1.94) 0.153 1.20 (0.76–1.90) 0.442 1.00 (0.57–1.78) 0.993
Kyphosis 1.83 (1.43–2.34) <0.001 1.64 (1.23–2.19) 0.001 1.80 (1.32–2.46) <0.001
Malignancy within 5 years 0.99 (0.71–1.38) 0.944 0.80 (0.52–1.23) 0.307 0.84 (0.52–1.36) 0.482
Osteoarthritis knee 1.00 (0.81–1.23) 0.987 0.98 (0.75–1.27) 0.878 1.05 (0.79–1.40) 0.733
Peptic ulcer 1.12 (0.78–1.62) 0.545 0.98 (0.63–1.54) 0.934 0.96 (0.57–1.62) 0.891
P≤0.05 values are in bold
Model 1: unadjusted model; model 2: adjusted for age, BMI, educational level, history of smoking and marital status; model 3: adjusted
for age, BMI, history of smoking, educational level, marital status and other co-existing chronic diseases
CKD chronic kidney disease, COAD chronic obstructive airways disease
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strength in women. Although it is well established that
the presence of chronic diseases increases with age,
older age is an un-modifiable risk factor. Handgrip
strength, however, is an objectively measured parameter
that could potentially reflect multimorbidity. Research
has shown that low handgrip strength was linked to
premature mortality (Sasaki et al. 2007); therefore, im-
proving handgrip strength or muscle strength could be a
possible way to reduce the likelihood of premature
mortality by reducing the number of chronic diseases
present. Although the current study did not establish the
causality between handgrip strength and overall health,
previous studies suggested that enhancing handgrip
strength may be beneficial to physiological systems
other than muscular system. For example, isometric
handgrip training for 5 to 6 weeks has been demonstrat-
ed to reduce resting arterial blood pressure (Peters et al.
2006; Taylor et al. 2003), which is probablymediated by
the autonomic control (Taylor et al. 2003) and myocar-
dial mechanisms (Millar et al. 2009). In addition, a
number of cytokines, growth hormones and hormones
are produced by muscle, such as myostatin and IGF-I.
Myostatin is mainly produced by skeletal muscle, and it
inhibits myoblast differentiation and proliferation
(McPherron et al. 1997). Subjects with chronic heart
failure had higher expression of myostatin in skeletal
muscle (Lenk et al. 2011) and higher serum level of
myostatin latent complex (George et al. 2010), after
12 weeks of exercise training, myostatin in skeletal
muscle of chronic heart failure patient was significantly
reduced (Lenk et al. 2011). Although circulating IGF-I
is mainly produced by the liver and partly produced by
skeletal muscle, previous study showed that muscle
IGF-I has a more significant role in growth and
Table 4 Odds ratio and 95% CI of chronic diseases per increase in age or per SD reduction in handgrip strength in the multivariable
model
Chronic disease Men (n0748) Women (n0397)
Chronological age HGS Chronological age HGS
OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value
Anaemia 0.97 (0.86–1.09) 0.605 0.68 (0.28–1.63) 0.384 0.99 (0.92–1.05) 0.652 1.83 (1.14–2.92) 0.012
Anxiety 0.96 (0.86–1.06) 0.424 3.57 (1.46–8.77) 0.005 0.81 (0.66–0.99) 0.040 1.46 (0.36–6.02) 0.597
Cataract 1.06 (1.01–1.11) 0.025 1.21 (0.84–1.75) 0.312 1.09 (1.05–1.13) <0.001 0.91 (0.71–1.17) 0.457
Cerebral vascular
accident (stroke)
1.03 (0.98–1.10) 0.272 1.68 (1.10–2.58) 0.017 1.02 (0.95–1.10) 0.586 1.29 (0.78–2.11) 0.320
CKD stage 3 or above 1.06 (0.99–1.14) 0.105 2.76 (1.59–4.78) <0.001 1.14 (1.06–1.24) 0.001 1.04 (0.64–1.68) 0.868
COAD 0.92 (0.84–1.02) 0.100 2.19 (1.05–4.55) 0.036 0.95 (0.67–1.34) 0.752 4.93 (0.50–48.85) 0.172
Depression 1.12 (0.98–1.29) 0.102 0.35 (0.11–1.10) 0.072 0.96 (0.87–1.07) 0.509 0.74 (0.35–1.54) 0.420
Diabetes 1.00 (0.97–1.04) 0.864 1.28 (0.99–1.66) 0.063 1.02 (0.98–1.06) 0.361 1.21 (0.90–1.63) 0.208
Hepatitis B 1.00 (0.92–1.09) 0.921 1.56 (0.78–3.12) 0.209 0.94 (0.83–1.06) 0.295 0.65 (0.26–1.64) 0.363
History of fall in the
past 12 months
1.03 (0.99–1.06) 0.180 1.31 (0.99–1.73) 0.059 0.97 (0.94–1.00) 0.064 1.44 (1.15–1.81) 0.002
Hyperlipidaemia 1.00 (0.97–1.04) 0.792 0.99 (0.76–1.28) 0.932 0.99 (0.96–1.03) 0.693 0.89 (0.68–1.17) 0.390
Hypertension 1.06 (1.03–1.09) <0.001 0.99 (0.80–1.22) 0.901 1.06 (1.03–1.10) <0.001 1.02 (0.79–1.30) 0.906
Hyperthyroidism 0.99 (0.92–1.05) 0.670 1.92 (1.11–3.30) 0.019 0.91 (0.85–0.97) 0.004 1.11 (0.68–1.81) 0.689
Ischemic heart diseases 1.07 (1.02–1.13) 0.011 1.32 (0.90–1.93) 0.157 1.09 (0.98–1.21) 0.135 1.00 (0.57–1.78) 0.993
Kyphosis 1.05 (1.01–1.10) 0.025 1.22 (0.88–1.67) 0.231 1.03 (0.98–1.07) 0.256 1.80 (1.32–2.46) <0.001
Malignancy within
5 years
1.04 (0.98–1.10) 0.180 1.16 (0.75–1.79) 0.499 1.04 (0.98–1.11) 0.182 0.84 (0.52–1.36) 0.482
Osteoarthritis knee 1.01 (0.98–1.04) 0.598 1.02 (0.78–1.32) 0.905 1.00 (0.96–1.04) 0.841 1.05 (0.79–1.40) 0.733
Peptic ulcer 1.01 (0.96–1.06) 0.771 0.90 (0.62–1.31) 0.570 1.04 (0.96–1.12) 0.326 0.96 (0.57–1.62) 0.891
P≤0.05 values are in bold
Model was mutually adjusted for age and handgrip strength T-score, and further adjusted for BMI, history of smoking, educational
level, marital status and other co-existing chronic diseases
HGS handgrip strength
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development than hepatic IGF-I (Klover and
Hennighausen 2007; Yakar et al. 1999). Improving
muscle strength by means of resistance training may
be a feasible strategy for improving general health and
decrease risk for multiple chronic diseases.
There are several strengths in the current study. Our
study was confined to people from southern China,
therefore minimizing the heterogeneity of results due
to the large differences among people with different
lifestyles and/or genetic components. We also adjusted
for BMI in our analysis in order to overcome the issue
related to the influence of body weight on handgrip
strength (Foley et al. 1999). Since occurrences of
some diseases are highly correlated, we adjusted for
Fig. 1 Mean age of subjects
with various number of
chronic diseases in men
(n0748; upper panel) and
women (n0397; lower
panel). Values presented are
means and 95% confidence
intervals adjusted for hand-
grip strength, BMI, history
of smoking, educational level
and marital status. P values
represent tests for linear trend
in age across subjects with
different number of chronic
diseases. *0.01<P≤0.05;
**P≤0.01
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other co-existing diseases in model 3 (Tables 2 and 3)
in order to take account for it.
Several limitations of this study warrant discussion.
First, the cross-sectional design does not establish a
casual relation between handgrip strength and multimor-
bidity examined in this study. Although the self-reported
disease status was validated using the computerized pa-
tient record system of the Hong Kong Hospital
Authority, possibility of false negative still exists for
those asymptomatic and undiagnosed chronic diseases.
Moreover, we cannot determine whether the observed
handgrip strength was pathological or they were the
consequences of having multimorbidity. Nevertheless,
several prospective studies suggested that handgrip
strength may precede some chronic diseases. In addi-
tion, multimorbidity and frailty are closely related, since
handgrip strength is considered as one of the criteria of
frailty in Study of Osteoporotic Fractures frailty index
(Fried et al. 2001), we did not evaluate how frailty might
affect our current findings. Although we have adjusted
several confounding factors such as BMI, educational
level and marital level (Marengoni et al. 2008; Taylor et
al. 2010) in the analysis, we were unable to adjust for
socioeconomic status and waist circumferences in the
analysis, since these two factors were not included in
our study.
Fig. 2 Mean handgrip
strength T-score of subjects
with various number of
chronic diseases in men
(n0748; upper panel) and
women (n0397; lower
panel). Values presented are
means and 95% confidence
intervals adjusted for age,
BMI, history of smoking,
educational level and marital
status. P values represent
tests for linear trend in age
and handgrip strength
T-score across subjects with
different number of chronic
diseases. *0.01<P≤0.05;
**P≤0.01
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In our questionnaire, we set all unknown or unsure
answers to missing, thus leading to a high prevalence of
missing data in our current study. Yet we found no
material differences between the groups of subjects
who were included and those excluded from the current
study on several key variables such as age, handgrip
strength T-score, and BMI. Hence, we believe the re-
duced number of subjects included in the study resulted
in lowered statistical power. Finally, since we tested the
associations between handgrip strength and 18 chronic
diseases, an alternative p value of 0.0028 (0.05/18 tests)
may be considered as the significant level to account for
multiple testing. Thus, results from Tables 2, 3 and 4
should be interpreted with caution.
In conclusion, handgrip strength is associated with
multiple chronic diseases in men and women, even
accounted for age, BMI, history of smoking, educational
level, marital status and comorbidity. It is also associated
with multimorbidity. In addition, handgrip strength
appeared to be a more useful marker of multimorbidity
than chronological age in men. Since it is an objective
parameter assessing muscle strength, which is affecting
and controlled by multiple physiological system, future
clinical trial is warranted to investigate its usefulness in
intervention or prevention of multimorbidity, and hence
possibly preventing premature mortality.
Open Access This article is distributed under the terms of the
Creative Commons Attribution License which permits any use,
distribution, and reproduction in any medium, provided the
original author(s) and the source are credited.
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